Evaluation of Prognostic Monitoring for Triple Negative Breast Cancer Patients

Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab

NCT05877859 ·Status: RECRUITING

68Ga FAPI PET/CT Evaluation of Axillary Lymph Node Status After Neoadjuvant Therapy in Patients With Clinical Axillary Lymph Node Positive Breast Cancer

NCT06559371 ·Status: RECRUITING

CT-based Radiomics of ALN pCR (ypN0) in Breast Cancer Undergoing NAC

NCT04457700 ·Status: UNKNOWN

PCI in Advanced Triple Negative Breast Cancer Patients Who Response to 1st Line Chemotherapy

NCT02448576 ·Status: UNKNOWN ·Phase: NA

Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mm

NCT02266420 ·Status: COMPLETED ·Phase: NA

IL-6 and IL-8 Level of Blood and Pleural Effusion During Chemotherapy in Metastatic Breast Cancer

NCT01543126 ·Status: TERMINATED

Sentinel Lymph Node Biopsy With or Without Para-Sentinel Lymph Node Dissection in Breast Cancer

NCT02651142 ·Status: UNKNOWN ·Phase: NA

Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer

NCT01514565 ·Status: UNKNOWN

Mutation of BRCA1/2 and Other Potential Genes in Triple-negative Breast Cancer

NCT02670668 ·Status: UNKNOWN ·Phase: NA

Triple Negative Breast Cancer: Study of Molecular and Genetic Factors

NCT01434420 ·Status: UNKNOWN ·Phase: NA

Impact of a Predictive Model on Sentinel Lymph Node Biopsy in Initially Lymph Node-positive, HER2-positive Breast Cancer

NCT06149377 ·Status: COMPLETED

Triple-negative Breast Cancer: a New Perspective on Biomarkers

NCT03539965 ·Status: COMPLETED

Inflammatory Blood Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

NCT05468710 ·Status: UNKNOWN

Sentinel Lymph Node Biopsy in Clinically Node-negative Early Breast Cancer Patients After Neoadjuvant Chemotherapy

NCT03381092 ·Status: UNKNOWN

Radiological Prediction of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer

NCT06879704 ·Status: RECRUITING ·Phase: NA

Prediction of Axillary Lymph Node Metastasis Status in Breast Cancer Based on PET/CT Radiomics

NCT05826197 ·Status: UNKNOWN

A Multicenter Prospective Observational Cohort Based on a Breast Cancer Medical Record Database in China

NCT06591039 ·Status: RECRUITING

Triple Negative Breast Cancer Biomarker Study

NCT01111175 ·Status: COMPLETED

The Diagnosis and Prognosis of Nonpalpable Breast Cancer Detected by the US vs Mammography: a Clinical Noninferiority Trial.

NCT04360616 ·Status: UNKNOWN

Dynamic Monitoring of HER2 and ctDNA Specific Mutations in Patients With Recurrent or Metastatic Breast Cancer by Digital PCR

NCT03947736 ·Status: UNKNOWN

VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study

NCT06409221 ·Status: ENROLLING_BY_INVITATION

Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technology

NCT05441098 ·Status: UNKNOWN

Prognostic Value of Biomarkers in HR + / HER2 - Advanced Breast Cancer

NCT04683770 ·Status: UNKNOWN

Use of INnovative and Micro-INvasive TEchniques for the Early Identification of Breast Cancer Patients Benefitting From Neo-adjuvant Therapy

NCT05846997 ·Status: UNKNOWN

Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant Chemotherapy

NCT06559696 ·Status: RECRUITING ·Phase: PHASE3